CClinicalTrials.gg
CompletedNCT03452410Updated Oct 11, 2019

MRIPositive Diagnosis of Vestibular Neuritis Using Fluid Attenuated Inversion Recuperation (FLAIR) Sequence on a 1.5 Tesla

An observational study in Vestibular Neuritis, sponsored by University Hospital, Strasbourg, France. Completed at 1 site in France. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2019-10-11.

Sponsored by University Hospital, Strasbourg, France · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
35
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Our objective is to allow positive MRI diagnosis of vestibular neuritis by highlighting contrast enhancement of the vestibular nerve on the pathological side of the FLAIR sequence acquired 1h after intravenous gadolinium injection in patients with typical vestibular neuritis. At present, the diagnosis is based on a combination clinical examination / video-head impulse test, and no imaging examination allows the diagnosis to be positive.

02

Conditions studied

  • Vestibular Neuritis

Keywords

  • Vestibular neuritis
  • Magnetic resonance imaging (MRI)
  • Vertigo
  • Fluid attenuated inversion recuperation (FLAIR)
03

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Patient with typical unilateral vestibular neuritis during ENT examination with videonystagmograph

Inclusion criteria

  • Age 18-80 years
  • Presence of a typical unilateral vestibular neuritis during the ENT examination with videonystagmography
  • Subject having his agreement for the use of his medical data for research purposes.

Exclusion criteria

Exclusion Criteria:

  • Special clinical forms of the disease: doubtful or atypical forms, especially the presence of deafness
  • Treatments and related interfering diseases, antecedents: antecedents of neuritis for controls, presence of vertigo, bilateral involvement
  • Impossibility to give the subject information enlightened (subject in emergency situation, difficulties of understanding the subject, ...)
  • Subject under the protection of justice
  • Subject under guardianship or curatorship
04

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
35 participants (actual)
Patient registry
No
05

What researchers measure

Primary outcomes

  1. Diagnosis of vestibular neuritis

    Time frame: one hour after intravenous gadolinium injection

06

Study locations

1 site
  • Service Imagerie 1
    Strasbourg, 67098, France
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03452410
Lead sponsor
University Hospital, Strasbourg, France
Responsible party
Sponsor
First posted
Mar 2, 2018
Start date
Feb 23, 2018
Primary completion
Feb 23, 2019
Completion
Feb 23, 2019
Last update
Oct 11, 2019

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion